The Bioscience Association of Maine strongly opposes LD 1422, “An Act To Allow Maine Residents To Personally Import Medications as Permitted under the Federal Food, Drug, and Cosmetic Act”. This legislation, if passed, will present a great risk to the public health of Maine residents and will also open the State of Maine to additional costly and unnecessary litigation. BAM is of the opinion that the legislation outlined in LD 1422 is misguided and we feel inappropriately addresses the issue it purportedly seeks to remedy. Read full statement here
Bioscience Association of Maine Strongly Opposes LD 1422
Related Posts
Portland startup Marin Skincare launches lobster-based lip treatment
Portland startup Marin Skincare, known for its “lobster lotion,” is expanding that product line to include lip treatments. Founded out of the University...
UMaine scientists use eDNA to enhance river herring recovery research in Penobscot River
University of Maine researchers are seeking to gain more insight into river herring recovery in the Penobscot River using a novel...
FocusMaine co-founder named group’s next president
Nearly a decade after Andrea Cianchette Maker joined forces with Michael Dubyak to launch FocusMaine, Maker will lead the organization as...